Physician

Ma'An Nasir, M.D.

According to 2025 Medicare claims, Ma'An Nasir, M.D. (NPI: 1629177241) practices ophthalmology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is CALIFORNIA RETINA CONSULTANTS (NPI: 1386737617; TIN: 223697030) and primary practice location at 93103-4223. Nasir is affiliated with the Aledade A3299 CA MSSP Enhanced (ACO ID: A3299), participating under the MSSP model.

Nasir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 981 traditional Medicare patients, billed 25,232 HCPCS/CPT codes, and received $2,540,413 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,009 prescription claims across 254 beneficiaries totaling $55,858 in drug costs, led by Ketorolac Tromethamine (Ketorolac Tromethamine). Open Payments data shows 3 records totaling $72. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.3M2015 Medicare payment: $4,232,770 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,048,317 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,113,209 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,059,077 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,277,838 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,775,531 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,721,571 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,333,104 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,997,879 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,540,413 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,40029,237$4,232,770
20161,34727,279$4,048,317
20171,34327,143$4,113,209
20181,34127,136$4,059,077
20191,37527,587$4,277,838
20201,18820,884$3,775,531
20211,16019,899$3,721,571
20221,10518,912$3,333,104
20231,01821,268$2,997,879
202498125,232$2,540,413

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$95K2015 Drug cost: $64,389 (USD; Tot_Drug_Cst)2016 Drug cost: $68,189 (USD; Tot_Drug_Cst)2017 Drug cost: $83,435 (USD; Tot_Drug_Cst)2018 Drug cost: $94,920 (USD; Tot_Drug_Cst)2019 Drug cost: $85,585 (USD; Tot_Drug_Cst)2020 Drug cost: $84,184 (USD; Tot_Drug_Cst)2021 Drug cost: $79,007 (USD; Tot_Drug_Cst)2022 Drug cost: $80,848 (USD; Tot_Drug_Cst)2023 Drug cost: $72,183 (USD; Tot_Drug_Cst)2024 Drug cost: $55,858 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015262887$64,389
2016276917$68,189
20173021,150$83,435
20183271,234$94,920
20193391,510$85,585
20203071,448$84,184
20212931,295$79,007
20222771,187$80,848
20232581,039$72,183
20242541,009$55,858

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2191,426$102
92014Established patient complete exam of visual system8231,442$95
92012Established patient problem focused exam of visual system270629$69
92134Imaging of retina9352,842$32
92202Extended exam of the back part of the eye with optic nerve drawing247314$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ketorolac TromethamineKetorolac Tromethamine32315,541$6,575
Bromfenac SodiumBromfenac Sodium12422$4,993
LumiganBimatoprost17495$4,937
ProlensaBromfenac Sodium13410$4,550
Prednisolone AcetatePrednisolone Acetate943,367$3,762

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$72Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ma'An Nasir, M.D.?

Tedicare shows public-source Medicare data for Ma'An Nasir, M.D. (NPI 1629177241), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ma'An Nasir, M.D. have ACO affiliation data?

Ma'An Nasir, M.D. is shown with ACO affiliation data for Aledade A3299 CA MSSP Enhanced (MSSP, ACO ID A3299).

What billing organization is linked to Ma'An Nasir, M.D.?

Ma'An Nasir, M.D. is linked to CALIFORNIA RETINA CONSULTANTS (billing NPI 1386737617) in the available physician profile data.

Does Ma'An Nasir, M.D. have Open Payments data?

Ma'An Nasir, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.